Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2015 Jul-Sep;6(3):166-8.
doi: 10.4103/0976-500X.162009.

Nebivolol-induced gynecomastia

Affiliations
Case Reports

Nebivolol-induced gynecomastia

Erkan Köklü et al. J Pharmacol Pharmacother. 2015 Jul-Sep.

Abstract

Adverse drug reactions play a substantial role in the etiology of gynecomastia. Gynecomastia as an adverse drug reaction, related to some cardiovascular drugs, has been reported in literature. Nebivolol is a third generation beta-blocker, and gynecomastia as an adverse effect on the consumption of this drug has not been reported in any article yet. We herein present the case of a 42-year-old male, who developed bilateral gynecomastia following nebivolol use and complete regression after discontinuation of nebivolol. Other reasons causing gynecomastia were excluded. Discontinuation of the responsible drug is quite sufficient with regard to the treatment of drug-induced gynecomastia, without any pharmacological or surgical treatment.

Keywords: Antihypertensive therapy; drug-induced gynecomastia; nebivolol.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Bilateral gynecomastia
Figure 2
Figure 2
Bilateral gynecomastia
Figure 3
Figure 3
Bilateral glandular tissue growth in the retroareolar region of the breast demonstrated in mammography

References

    1. Donegan WL. Common benign contitions of the breast. Gynecomastia. In: Donegan WL, Spratt JS Jr, editors. Cancer of the Breast. London: W.B. Saunders; 1995. pp. 100–3.
    1. Braunstein GD. Gynecomastia. N Engl J Med. 1993;328:490–5. - PubMed
    1. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method of estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–45. - PubMed
    1. Carlson HE. Gynecomastia. N Engl J Med. 1980;303:795–9. - PubMed
    1. Thomson DF, Carter JR. Drug-induced gynecomastia. Pharmacotherapy. 1993;13:37–45. - PubMed

Publication types

LinkOut - more resources